Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Syneos

BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake

Activist investor Elliott has reportedly built a $1 billion stake in BioMarin Pharmaceutical, Reuters reported Tuesday as BMRN stock rocketed.

Investors Business Daily

How execs cash in on competitors' stocks

CEOs make massive bets on the stocks of direct competitors and partners — and with exquisite timing

Salon

Syneos Health Shares Jump On Better Than Expected Q1 Earnings, FY22 Outlook

Syneos Health Inc's (NASDAQ:SYNH) Q1 revenue increased 10.5% on a reported basis and 11.7% on a constant currency (CC) basis to $1.34 billion, beating the consensus of $1.32 billion. Clinical Solutions revenue increased 8.4% (+9.6% CC) to $1.02 billion. Acquisitions contributed approximately 1,00 basis points to Clinical Solutions' reported revenue growth. Commercial Solutions…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

NOVN: A Banner Year for Novan - 2021 Results

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT

Benzinga

Syneos Health Reports Mixed Q4 Earnings, Provides FY22 Guidance

Syneos Health Inc's (NASDAQ: SYNH) Q4 revenue increased 20.5% on a reported basis and 20.8% on a constant currency (CC) basis to

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Biomarin Pharmaceutical

15 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.